Page 42 - Read Online
P. 42

Garg et al. Hepatoma Res 2019;5:39  I  http://dx.doi.org/10.20517/2394-5079.2019.009                                             Page 11 of 11

               41.  Ramalho M, Matos AP, AlObaidy M, Velloni F, Altun E, et al. Magnetic resonance imaging of the cirrhotic liver: diagnosis of
                   hepatocellular carcinoma and evaluation of response to treatment - Part 1. Radiol Bras 2017;50:38-47.
               42.  Rimola J, Forner A, Tremosini S, Reig M, Vilana R, et al. Non-invasive diagnosis of hepatocellular carcinoma </= 2 cm in cirrhosis.
                   Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J Hepatol 2012;56:1317-23.
               43.  Tang A, Bashir MR, Corwin MT, Cruite I, Dietrich CF, et al. Evidence supporting LI-RADS major features for CT- and MR imaging-
                   based diagnosis of hepatocellular carcinoma: a systematic review. Radiology 2018;286:29-48.
               44.  Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, et al. NAFLD may be a common underlying liver disease in patients
                   with hepatocellular carcinoma in the United States. Hepatology 2002;36:1349-54.
               45.  Ehman EC, Behr SC, Umetsu SE, Fidelman N, Yeh BM, et al. Rate of observation and inter-observer agreement for LI-RADS major
                   features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol (NY) 2016;41:963-9.
               46.  Oliver JH 3rd, Baron RL, Federle MP, Rockette HE Jr. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT
                   imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging. AJR Am J Roentgenol
                   1996;167:71-7.
               47.  Luca A, Caruso S, Milazzo M, Mamone G, Marrone G, et al. Multidetector-row computed tomography (MDCT) for the diagnosis of
                   hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological
                   correlation with liver explants. Eur Radiol 2010;20:898-907.
               48.  Serste T, Barrau V, Ozenne V, Vullierme MP, Bedossa P, et al. Accuracy and disagreement of computed tomography and magnetic
                   resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. Hepatology 2012;55:800-6.
               49.  Iannaccone R, Piacentini F, Murakami T, Paradis V, Belghiti J, et al. Hepatocellular carcinoma in patients with nonalcoholic fatty liver
                   disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology 2007;243:422-30.
               50.  Khan AS, Hussain HK, Johnson TD, Weadock WJ, Pelletier SJ, et al. Value of delayed hypointensity and delayed enhancing rim in
                   magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver. J Magn Reson Imaging 2010;32:360-6.
               51.  Ueda K, Matsui O, Kawamori Y, Nakanuma Y, Kadoya M, et al. Hypervascular hepatocellular carcinoma: evaluation of
                   hemodynamics with dynamic CT during hepatic arteriography. Radiology 1998;206:161-6.
   37   38   39   40   41   42   43   44   45   46   47